Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DIAMOND® for the Treatment of Type 2 Diabetes: Can Blood Triglycerides Level be the Predictor for Therapy Efficiency A Multicentre, Prospective, Semi-randomized Study

NCT02079376 is registered in ClinicalTrials.gov with MetaCure Limited as lead sponsor.

NCT NCT02079376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02079376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DIAMOND® for the Treatment of Type 2 Diabetes: Can Blood Triglycerides Level be the Predictor for Therapy Efficiency A Multicentre, Prospective, Semi-randomized Study
Lead sponsor
MetaCure Limited
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2013
Completion date
December 31, 2016
Enrollment
45 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes